FDA Adverse Event Injury Summary report: N

ELUPRO ANTIBIOTIC-ELUTING BIOENVELOPE

MDR report key: 22777203 · Received August 11, 2025

Report

Report Number
3005619880-2025-00006
Event Type
Injury
Date Received
August 11, 2025
Date of Event
May 30, 2025
Report Date
August 11, 2025
Manufacturer
ELUTIA INC.
Product Code
FTM
UDI-DI
00859389005348
PMA / PMN Number
K233991
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ELUTIA LHR REVIEW COMPLETED ON 08/07/2025 FOR LOT: M25B1030 AND SUBASSEMBLY LOT: M25A1007. NO DISCREPANCIES IN THE MANUFACTURING PROCESS WERE NOTED IN EITHER BATCH RECORD DURING REVIEW. IT IS NOTED THAT PER THE INSTRUCTIONS FOR USE (IFU - ART20837 REV. A, IFU ELUPRO ANTIBIOTIC-ELUTING BIOENVELOPE) PROVIDED WITH THE FINISHED ELUPRO DEVICE, "HEMATOMA" IS LISTED WITHIN THE POTENTIAL COMPLICATIONS ASSOCIATED WITH DEVICE USAGE. HEMATOMA IS A KNOWN COMPLICATION WITH THE IMPLANT OF A CARDIAC IMPLANTABLE DEVICE FOR CARDIAC SURGICAL PROCEDURE.

Description of Event or Problem · 0

EMAIL WAS RECEIVED FROM THE ELUTIA REPRESENTATIVE REGARDING A PATIENT IN AN ELUTIA REGISTRY STUDY. IT WAS REPORTED THAT ON (B)(6) 2025, THE PATIENT HAD A POCKET REVISION WITH A PACEMAKER IMPLANT ALONG WITH THE IMPLANT OF A LARGE ELUPRO ANTIBIOTIC-ELUTING BIOENVELOPE (MODEL: CMCV-124-LRG, LOT: M25B1030). ON 05/30/2025, SITE BECAME AWARE THAT THE PATIENT DEVELOPED A HEMATOMA AND WAS TREATED WITH ORAL ANTIBIOTICS (DOXYCYCLINE) AS WELL AS OXYCODONE. ON 06/10/2025 THE SITE NOTED THE HEMATOMA WAS NOT RESOLVED AND THE PATIENT WAS HOSPITALIZED. THE HEMATOMA WAS DRAINED AND THE PATIENT WAS TREATED AGAIN WITH ORAL ANTIBIOTICS (DOXYCYCLINE). NO FURTHER DETAILS ARE AVAILABLE REGARDING THIS EVENT BUT IF ELUTIA RECEIVES MORE INFORMATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2159784 ELUPRO ANTIBIOTIC-ELUTING BIOENVELOPE CANGAROO RM ANTIBACTERIAL ENVELOPE FTM ELUTIA INC. CMCV-124-LRG M25B1030 00859389005348

Patients

Seq Age Sex Outcome Treatment
1 69 YR Male Required Intervention| H